Department of Microbiology
Gene S. Tan has not added Biography.
If you are Gene S. Tan and would like to personalize this page please email our Author Liaison for assistance.
Rabies virus nucleoprotein as a carrier for foreign antigens.
Proceedings of the National Academy of Sciences of the United States of America Jun, 2004 | Pubmed ID: 15197258
Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach.
Virology Jan, 2005 | Pubmed ID: 15582655
The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines.
Journal of neurovirology Feb, 2005 | Pubmed ID: 15804964
The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription.
Proceedings of the National Academy of Sciences of the United States of America Apr, 2007 | Pubmed ID: 17438267
PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity.
Journal of virology Oct, 2008 | Pubmed ID: 18667490
Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Vaccine Nov, 2008 | Pubmed ID: 18804506
Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers.
PLoS pathogens Jun, 2009 | Pubmed ID: 19543379
Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.
The Journal of infectious diseases Oct, 2009 | Pubmed ID: 19764884
Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein.
Science signaling Jan, 2010 | Pubmed ID: 20086240
Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
PLoS pathogens Feb, 2010 | Pubmed ID: 20195520
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2010 | Pubmed ID: 20956293
Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses.
Proceedings of the National Academy of Sciences of the United States of America Feb, 2012 | Pubmed ID: 22308500
Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes.
Journal of virology May, 2012 | Pubmed ID: 22398287
A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo.
Journal of virology Jun, 2012 | Pubmed ID: 22491456
Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice.
Journal of virology Oct, 2012 | Pubmed ID: 22787225
A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.
Journal of virology Nov, 2012 | Pubmed ID: 22896619
A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates.
PloS one , 2012 | Pubmed ID: 22928001
In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies.
Journal of virology Aug, 2013 | Pubmed ID: 23698304
Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.
Journal of virology Mar, 2014 | Pubmed ID: 24403585
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo.
Nature medicine Feb, 2014 | Pubmed ID: 24412922
Divergent H7 immunogens offer protection from H7N9 virus challenge.
Journal of virology Apr, 2014 | Pubmed ID: 24453375
Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.
Journal of virology Dec, 2014 | Pubmed ID: 25210195
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
The Journal of clinical investigation Mar, 2015 | Pubmed ID: 25689254
Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.
mBio Mar, 2015 | Pubmed ID: 25759506
Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.
Antimicrobial agents and chemotherapy Jul, 2015 | Pubmed ID: 25941218
Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.
Vaccine Jun, 2015 | Pubmed ID: 26026378
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy.
Cell Jul, 2015 | Pubmed ID: 26140596
Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Journal of virology Oct, 2015 | Pubmed ID: 26512088
Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins.
Journal of virology Jan, 2016 | Pubmed ID: 26764009
Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.
mBio Mar, 2016 | Pubmed ID: 27006464
Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection.
PLoS pathogens Apr, 2016 | Pubmed ID: 27081859
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
Cell host & microbe Jun, 2016 | Pubmed ID: 27281570
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
Proceedings of the National Academy of Sciences of the United States of America Oct, 2016 | Pubmed ID: 27647907
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
Proceedings of the National Academy of Sciences of the United States of America Oct, 2016 | Pubmed ID: 27698132
Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
mBio Oct, 2016 | Pubmed ID: 27703076
Synthetic TLR4 and TLR7 ligands work additively via MyD88 to induce protective antiviral immunity in mice.
Journal of virology Jul, 2017 | Pubmed ID: 28724768
Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.
Nature microbiology Aug, 2017 | Pubmed ID: 28827718
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice.
Nature communications 10, 2017 | Pubmed ID: 29018261
Whole-Genome Sequences of Zika Virus FLR Strains after Passage in Vero or C6/36 Cells.
Genome announcements Jan, 2018 | Pubmed ID: 29371358
Copyright © 2024 MyJoVE Corporation. 판권 소유